Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

4(44%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

33%

Ph phase_4

11%

Ph not_applicable

22%

Ph phase_1

11%

Ph phase_2

22%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

2(22.2%)

Phase 3Large-scale testing

3(33.3%)

Phase 4Post-market surveillance

1(11.1%)

N/ANon-phased studies

2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(8)

Completed(1)

Detailed Status

Recruiting4

Not yet recruiting3

Completed1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 22 (22.2%)

Phase 33 (33.3%)

Phase 41 (11.1%)

N/A2 (22.2%)

Trials by Status

recruiting444%

completed111%

enrolling_by_invitation111%

not_yet_recruiting333%

Recent Activity

4 active trials

Showing 5 of 9

enrolling_by_invitationnot_applicable

Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery

NCT07429760

recruitingnot_applicable

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07429760Not Applicable

Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery

Enrolling By Invitation

NCT07313215Not Applicable

Rifampin-combined Antibiotic Therapy for Staphylococcal PJI

Recruiting

NCT06905522Phase 3

A PAN-USR TB Multi-Center Trial

Recruiting

NCT07213765Phase 4

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

Recruiting

NCT06114628Phase 2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Recruiting

NCT07163143Phase 3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Not Yet Recruiting

NCT07129629Phase 2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Not Yet Recruiting

NCT07076225Phase 3

Ultra-Short Regimen for Elderly DS-TB

Not Yet Recruiting

NCT02457208Phase 1

PK Study of Anti-TB Drugs

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9